Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
Top Cited Papers
- 1 May 2001
- journal article
- clinical trial
- Published by Springer Nature in Gene Therapy
- Vol. 8 (10) , 746-759
- https://doi.org/10.1038/sj.gt.3301424
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 85 references indexed in Scilit:
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1995
- Immunosuppression by FK506 Markedly Prolongs Expression of Adenovirus-Delivered Transgene in Skeletal Muscles of Adult Dystrophic [mdx] MiceBiochemical and Biophysical Research Communications, 1995
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemiaSomatic Cell and Molecular Genetics, 1993
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- p53 and DNA polymerase α compete for binding to SV40 T antigenNature, 1987
- Role of Adenovirus Antigens in the Induction of Virus Neutralizing AntibodyJournal of General Virology, 1968